Anelixis Therapeutics, Inc.

Biotechnology company · Cambridge, Massachusetts, United States

Anelixis Therapeutics, Inc. is a biotechnology company headquartered in Cambridge, Massachusetts, United States. Its earliest recorded incorporation is in 2015. It has reported private securities offerings to the US SEC, most recently $1 million sold in a notice filed in 2019.

Profile compiled from public records. Is this your company? Request a correction or update

Anelixis Therapeutics at a glance

Typebiotechnology company

HeadquartersCambridge, Massachusetts, United States

Earliest incorporation on record2015

SEC CIK1704400

What does Anelixis Therapeutics do?

Private fundraising reported to the SEC

3 Form D notices; the most recent reported $1 million sold (2019).

Frequently asked questions about Anelixis Therapeutics

Where is Anelixis Therapeutics headquartered?

Anelixis Therapeutics, Inc. is headquartered in Cambridge, Massachusetts, United States.

What does Anelixis Therapeutics do?

Anelixis Therapeutics, Inc. is a biotechnology company.

When was Anelixis Therapeutics founded?

The earliest incorporation on record for Anelixis Therapeutics, Inc. is in 2015, according to public company registers.

Similar companies

Editas Medicine, Inc.Cambridge, Massachusetts, United States
Moderna, Inc.Cambridge, Massachusetts, United States
Relay Therapeutics, Inc.Cambridge, Massachusetts, United States
Beam Therapeutics Inc.Cambridge, Massachusetts, United States
Genzyme CorpCambridge, Massachusetts, United States
Neutrolis Inc.Cambridge, Massachusetts, United States
Biogen Inc.Cambridge, Massachusetts, United States
Black Diamond Therapeutics, Inc.Cambridge, Massachusetts, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences